Last reviewed · How we verify
carbamide peroxide
Carbamide peroxide is a marketed drug primarily indicated for earwax removal, with a key composition patent expiring in 2028. Its mechanism of breaking down earwax through hydrolysis provides a non-invasive and effective solution for patients. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | carbamide peroxide |
|---|---|
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Earwax removal
Common side effects
Key clinical trials
- Effectiveness of Dental Bleaching Using Different Designs of 3D-Printed and Conventional Customized Nightguards (NA)
- Clinical Evaluation of Enamel Microhardness Using Tooth Whitening Agents (NA)
- PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE (NA)
- At-home Bleaching Using Clear Retainers (NA)
- 16% Carbamide Peroxide Home Bleaching: Soft vs. Rigid Tray in a Randomized Blinded Equivalence Trial (NA)
- Effectiveness of 16% Carbamide Peroxide in Reducing Hypersensitivity During Alternate-day Home Bleaching (NA)
- A Comparative Study Between the Efficacy of Diode Laser and Nano-chitosan Gel on Activation of Non-vital in- Office Bleaching Agent (PHASE1)
- Effect of 1.5% Potassium Oxalate on the Control of Tooth Sensitivity and Color Change After Home Bleaching (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- carbamide peroxide CI brief — competitive landscape report
- carbamide peroxide updates RSS · CI watch RSS
- portfolio CI